Fluidigm Stock Price, News & Analysis (NASDAQ:FLDM)

$7.76 -0.21 (-2.63 %)
(As of 02/16/2018 04:00 PM ET)
Previous Close$7.76
Today's Range$7.67 - $8.38
52-Week Range$2.52 - $8.38
Volume331,349 shs
Average Volume228,242 shs
Market Capitalization$308.02 million
P/E Ratio-4.08
Dividend YieldN/A
Beta3.24

About Fluidigm (NASDAQ:FLDM)

Fluidigm logoFluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.

Receive FLDM News and Ratings via Email

Sign-up to receive the latest news and ratings for FLDM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Software & Technology Services
Sub-IndustryLife Sciences Tools & Services
SectorMedical
SymbolNASDAQ:FLDM
CUSIP34385P10
Phone650-266-6000

Debt

Debt-to-Equity Ratio5.00%
Current Ratio3.02%
Quick Ratio2.46%

Price-To-Earnings

Trailing P/E Ratio-4.08421052631579
Forward P/E Ratio-8.34
P/E GrowthN/A

Sales & Book Value

Annual Sales$101.94 million
Price / Sales2.94
Cash FlowN/A
Price / CashN/A
Book Value$1.83 per share
Price / Book4.24

Profitability

Trailing EPS($1.90)
Net Income$-60,530,000.00
Net Margins-59.38%
Return on Equity-116.02%
Return on Assets-13.64%

Miscellaneous

Employees589
Outstanding Shares38,650,000

Fluidigm (NASDAQ:FLDM) Frequently Asked Questions

What is Fluidigm's stock symbol?

Fluidigm trades on the NASDAQ under the ticker symbol "FLDM."

How were Fluidigm's earnings last quarter?

Fluidigm Co. (NASDAQ:FLDM) announced its quarterly earnings results on Thursday, February, 8th. The medical research company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.02. The medical research company earned $27.75 million during the quarter, compared to the consensus estimate of $27.14 million. Fluidigm had a negative return on equity of 116.02% and a negative net margin of 59.38%. The company's revenue for the quarter was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.32) EPS. View Fluidigm's Earnings History.

When will Fluidigm make its next earnings announcement?

Fluidigm is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Fluidigm.

Where is Fluidigm's stock going? Where will Fluidigm's stock price be in 2018?

1 brokers have issued 12-month price targets for Fluidigm's stock. Their forecasts range from $6.10 to $6.10. On average, they expect Fluidigm's share price to reach $6.10 in the next year. View Analyst Ratings for Fluidigm.

Who are some of Fluidigm's key competitors?

Who are Fluidigm's key executives?

Fluidigm's management team includes the folowing people:

  • Samuel D. Colella, Independent Chairman of the Board (Age 77)
  • Stephen Christopher Linthwaite, President, Chief Executive Officer, Chief Operating Officer, Director (Age 45)
  • Vikram Jog, Chief Financial Officer (Age 59)
  • William Maxwell Smith J.D., Executive Vice President - Legal Affairs, General Counsel, Secretary (Age 65)
  • Robert C. Jones, Executive Vice President - Research and Development (Age 60)
  • Jennifer Ling Lee, Principal Accounting Officer, Vice President, Controller (Age 53)
  • Mai Chan Yow, Executive Vice President - Worldwide Manufacturing and Managing Director (Age 56)
  • Nicolas M. Barthelemy, Director (Age 51)
  • Carlos V. Paya M.D., Ph.D., Director (Age 58)
  • Gerhard F. Burbach, Independent Director (Age 53)

Who owns Fluidigm stock?

Fluidigm's stock is owned by a variety of of institutional and retail investors. Top institutional investors include LEVIN CAPITAL STRATEGIES, L.P. (30.70%), Levin Capital Strategies L.P. (23.72%), BlackRock Inc. (5.65%), Renaissance Technologies LLC (2.08%), Healthcare Value Capital LLC (1.06%) and Bank of New York Mellon Corp (0.99%). Company insiders that own Fluidigm stock include Evan/ Fa Jones, Levin Capital Strategies, LP, Samuel D Colella, Stephen Christopher Linthwaite and Steven Mcphail. View Institutional Ownership Trends for Fluidigm.

Who sold Fluidigm stock? Who is selling Fluidigm stock?

Fluidigm's stock was sold by a variety of institutional investors in the last quarter, including Fuller & Thaler Asset Management Inc., Millennium Management LLC, Healthcare Value Capital LLC, Wasatch Advisors Inc. and Goldman Sachs Group Inc.. View Insider Buying and Selling for Fluidigm.

Who bought Fluidigm stock? Who is buying Fluidigm stock?

Fluidigm's stock was acquired by a variety of institutional investors in the last quarter, including Levin Capital Strategies L.P., BlackRock Inc., Alexandria Capital LLC, Renaissance Technologies LLC, Perkins Capital Management Inc., Two Sigma Investments LP, Acadian Asset Management LLC and Geode Capital Management LLC. Company insiders that have bought Fluidigm stock in the last two years include Levin Capital Strategies, LP, Samuel D Colella, Stephen Christopher Linthwaite and Steven Mcphail. View Insider Buying and Selling for Fluidigm.

How do I buy Fluidigm stock?

Shares of Fluidigm can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fluidigm's stock price today?

One share of Fluidigm stock can currently be purchased for approximately $7.76.

How big of a company is Fluidigm?

Fluidigm has a market capitalization of $308.02 million and generates $101.94 million in revenue each year. The medical research company earns $-60,530,000.00 in net income (profit) each year or ($1.90) on an earnings per share basis. Fluidigm employs 589 workers across the globe.

How can I contact Fluidigm?

Fluidigm's mailing address is 7000 Shoreline Court Suite 100, South San Francisco CA, 94080. The medical research company can be reached via phone at 650-266-6000.


MarketBeat Community Rating for Fluidigm (FLDM)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  330 (Vote Outperform)
Underperform Votes:  180 (Vote Underperform)
Total Votes:  510
MarketBeat's community ratings are surveys of what our community members think about Fluidigm and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Fluidigm (NASDAQ:FLDM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldBuyBuyBuy
Consensus Rating Score: 2.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.10$9.00$9.00$9.00
Price Target Upside: 5.54% upside44.69% upside44.69% upside44.69% upside

Fluidigm (NASDAQ:FLDM) Consensus Price Target History

Price Target History for Fluidigm (NASDAQ:FLDM)

Fluidigm (NASDAQ:FLDM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/8/2018Piper Jaffray CompaniesReiterated RatingHold$6.10HighView Rating Details
2/9/2017Cantor FitzgeraldSet Price TargetBuy$9.00N/AView Rating Details
8/5/2016MizuhoBoost Price TargetBuy$11.00 -> $12.00N/AView Rating Details
6/1/2016Deutsche BankInitiated CoverageBuyN/AView Rating Details
4/12/2016Leerink SwannLower Price TargetOutperform$20.00 -> $15.00N/AView Rating Details
(Data available from 2/17/2016 forward)

Earnings

Fluidigm (NASDAQ:FLDM) Earnings History and Estimates Chart

Earnings by Quarter for Fluidigm (NASDAQ:FLDM)

Fluidigm (NASDAQ FLDM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018($0.41)N/AView Earnings Details
2/8/2018Q4 2017($0.25)($0.27)$27.14 million$27.75 millionViewListenView Earnings Details
11/2/2017Q3 2017($0.37)($0.31)$25.50 million$24.75 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.60)($0.58)$23.50 million$23.90 millionViewListenView Earnings Details
5/4/2017Q1 2017($0.64)($0.41)$25.00 million$25.53 millionViewN/AView Earnings Details
2/8/2017Q4 2016($0.61)($0.61)$25.91 million$25.10 millionViewListenView Earnings Details
11/3/2016Q3($0.67)($0.68)$27.75 million$22.20 millionViewN/AView Earnings Details
8/4/2016Q2($0.58)($0.64)$29.62 million$28.20 millionViewN/AView Earnings Details
5/5/2016Q116($0.53)($0.40)$26.95 million$29.00 millionViewN/AView Earnings Details
2/4/2016Q4 2015($0.48)($0.38)$30.10 million$30.72 millionViewN/AView Earnings Details
10/29/2015Q315($0.55)($0.15)$27.54 million$28.60 millionViewListenView Earnings Details
8/6/2015Q215($0.48)($0.53)$30.43 million$28.62 millionViewListenView Earnings Details
5/7/2015Q115($0.40)($0.39)$30.70 million$26.70 millionViewListenView Earnings Details
2/5/2015Q414($0.43)($0.39)$33.34 million$33.50 millionViewListenView Earnings Details
10/30/2014Q314($0.04)($0.49)$29.20 million$29.60 millionViewN/AView Earnings Details
7/31/2014Q214($0.50)($0.45)$27.13 million$27.60 millionViewN/AView Earnings Details
5/5/2014Q1 2014($0.31)($0.19)$21.01 million$25.72 millionViewN/AView Earnings Details
2/6/2014Q413($0.15)($0.04)$20.73 million$20.90 millionViewN/AView Earnings Details
10/30/2013Q313($0.20)($0.06)$16.70 million$18.30 millionViewN/AView Earnings Details
8/1/2013Q2 2013($0.17)($0.07)$15.87 million$17.50 millionViewN/AView Earnings Details
5/1/2013Q1 2013($0.21)($0.21)$14.49 million$14.54 millionViewN/AView Earnings Details
2/12/2013Q4 2012($0.15)($0.14)ViewN/AView Earnings Details
11/7/2012Q312($0.21)($0.12)$13.35 million$12.60 millionViewN/AView Earnings Details
8/7/2012Q2 2012($0.25)($0.22)ViewN/AView Earnings Details
5/10/2012Q1 2012($0.26)($0.25)ViewN/AView Earnings Details
2/14/2012Q4 2011($0.21)($0.17)ViewN/AView Earnings Details
11/8/2011Q3 2011($0.23)($0.22)ViewN/AView Earnings Details
8/9/2011Q2 2011($0.22)($0.21)ViewN/AView Earnings Details
5/10/2011Q1 2011($0.28)($0.35)ViewN/AView Earnings Details
3/9/2011Q4 2010($1.25)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Fluidigm (NASDAQ:FLDM) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.93 EPS
Next Year EPS Consensus Estimate: $-0.74 EPS

Dividends

Dividend History for Fluidigm (NASDAQ:FLDM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Fluidigm (NASDAQ FLDM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.70%
Institutional Ownership Percentage: 94.79%
Insider Trades by Quarter for Fluidigm (NASDAQ:FLDM)
Institutional Ownership by Quarter for Fluidigm (NASDAQ:FLDM)

Fluidigm (NASDAQ FLDM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/7/2018Levin Capital Strategies, L.P.InsiderBuy53,610$5.73$307,185.30View SEC Filing  
2/5/2018Levin Capital Strategies, L.P.InsiderBuy50,987$5.96$303,882.52View SEC Filing  
2/1/2018Levin Capital Strategies, L.P.InsiderBuy152,891$6.18$944,866.38View SEC Filing  
1/23/2018Levin Capital Strategies, L.P.InsiderBuy6,871$6.57$45,142.47View SEC Filing  
1/16/2018Levin Capital Strategies, L.P.InsiderBuy887$6.68$5,925.16View SEC Filing  
1/10/2018Levin Capital Strategies, L.P.InsiderBuy100,576$6.34$637,651.84View SEC Filing  
1/3/2018Levin Capital Strategies, L.P.InsiderBuy29$6.63$192.27View SEC Filing  
12/29/2017Levin Capital Strategies, L.P.InsiderBuy11,230$5.94$66,706.20View SEC Filing  
12/28/2017Levin Capital Strategies, L.P.InsiderBuy30$5.82$174.60View SEC Filing  
12/27/2017Levin Capital Strategies, L.P.InsiderBuy27,100$5.88$159,348.00View SEC Filing  
12/15/2017Levin Capital Strategies, L.P.InsiderBuy24,175$5.84$141,182.00View SEC Filing  
12/12/2017Levin Capital Strategies, L.P.InsiderBuy18,569$5.84$108,442.96View SEC Filing  
12/4/2017Levin Capital Strategies, L.P.InsiderBuy8,409$5.48$46,081.32View SEC Filing  
11/29/2017Levin Capital Strategies, L.P.InsiderBuy20,380$5.71$116,369.80View SEC Filing  
11/17/2017Levin Capital Strategies, L.P.InsiderBuy6,880$5.05$34,744.00View SEC Filing  
11/8/2017Levin Capital Strategies, L.P.InsiderBuy54,900$5.26$288,774.00View SEC Filing  
10/25/2017Levin Capital Strategies, L.P.InsiderBuy4,227$5.42$22,910.34View SEC Filing  
10/23/2017Levin Capital Strategies, L.P.InsiderBuy22,363$5.47$122,325.61View SEC Filing  
10/19/2017Levin Capital Strategies, L.P.InsiderBuy60,000$4.55$273,000.00View SEC Filing  
10/17/2017Levin Capital Strategies, L.P.InsiderBuy144,200$4.59$661,878.00View SEC Filing  
10/10/2017Levin Capital Strategies, L.P.InsiderBuy95,843$4.57$438,002.51View SEC Filing  
10/9/2017Levin Capital Strategies, L.P.InsiderBuy50,000$4.59$229,500.00View SEC Filing  
9/12/2017Levin Capital Strategies, L.P.InsiderBuy60,000$5.25$315,000.00View SEC Filing  
8/17/2017Levin Capital Strategies, L.P.InsiderBuy465$3.66$1,701.90View SEC Filing  
8/10/2017Levin Capital Strategies, L.P.InsiderBuy4,003,129$3.30$13,210,325.70View SEC Filing  
8/9/2017Levin Capital Strategies, L.P.InsiderBuy1,549$3.18$4,925.82View SEC Filing  
8/8/2017Samuel D ColellaDirectorBuy35,895$2.77$99,429.1545,197View SEC Filing  
8/8/2017Stephen Christopher LinthwaiteCEOBuy45,000$2.66$119,700.00106,977View SEC Filing  
8/8/2017Steven McphailInsiderBuy20,000$3.00$60,000.0027,842View SEC Filing  
6/7/2017Evan/ Fa JonesDirectorSell10,900$4.54$49,486.00View SEC Filing  
5/9/2017Samuel D ColellaDirectorBuy7,500$5.93$44,475.0043,523View SEC Filing  
3/14/2017Samuel D ColellaDirectorBuy10,000$5.00$50,000.0043,523View SEC Filing  
12/14/2016Samuel D ColellaDirectorBuy5,000$7.39$36,950.0044,123View SEC Filing  
11/30/2016Samuel D ColellaDirectorBuy20,000$6.32$126,400.0019,123View SEC Filing  
11/30/2016Stephen Christopher LinthwaiteCEOBuy55,000$6.36$349,800.0058,000View SEC Filing  
11/7/2016Levin Capital Strategies, L.P.InsiderBuy159,200$4.44$706,848.00View SEC Filing  
11/2/2016Levin Capital Strategies, L.P.InsiderBuy48,302$4.44$214,460.88View SEC Filing  
10/1/2015Gajus Vincent WorthingtonCEOSell6,000$8.05$48,300.006,815View SEC Filing  
9/2/2015Gajus Vincent WorthingtonCEOSell12,000$11.53$138,360.006,815View SEC Filing  
6/16/2015Vikram JogCFOSell3,550$25.00$88,750.00View SEC Filing  
6/15/2015William Maxwell SmithEVPSell3,000$24.20$72,600.00View SEC Filing  
6/1/2015Gajus Vincent WorthingtonCEOSell6,000$23.71$142,260.00View SEC Filing  
4/20/2015Mai Chan YowInsiderSell15,300$44.73$684,369.00View SEC Filing  
4/17/2015Mai Chan YowInsiderSell4,700$44.04$206,988.00View SEC Filing  
4/17/2015William Maxwell SmithEVPSell3,000$43.05$129,150.00View SEC Filing  
4/8/2015Mai Chan YowInsiderSell30,000$42.67$1,280,100.00View SEC Filing  
4/7/2015Vikram JogCFOSell3,950$40.81$161,199.50View SEC Filing  
4/1/2015Gajus Vincent WorthingtonCEOSell6,000$40.02$240,120.00View SEC Filing  
4/1/2015Robert C JonesEVPSell3,000$41.63$124,890.00View SEC Filing  
3/16/2015William Maxwell SmithEVPSell3,000$40.87$122,610.00View SEC Filing  
3/9/2015Vikram JogCFOSell3,950$41.48$163,846.00View SEC Filing  
3/2/2015Evan/ Fa JonesDirectorSell7,500$44.15$331,125.00View SEC Filing  
3/2/2015Gajus Vincent WorthingtonCEOSell6,000$43.77$262,620.00View SEC Filing  
3/2/2015Robert C JonesEVPSell3,000$43.78$131,340.00View SEC Filing  
2/20/2015Samuel D ColellaDirectorSell44,540$38.97$1,735,723.80View SEC Filing  
2/2/2015Gajus Vincent WorthingtonCEOSell6,000$38.15$228,900.00View SEC Filing  
1/15/2015William Maxwell SmithEVPSell3,000$34.24$102,720.00View SEC Filing  
1/2/2015Gajus Vincent WorthingtonCEOSell6,000$33.37$200,220.00View SEC Filing  
12/15/2014William Maxwell SmithEVPSell3,000$27.20$81,600.00View SEC Filing  
12/12/2014Evan/ Fa JonesDirectorSell8,352$27.44$229,178.88View SEC Filing  
12/9/2014Evan/ Fa JonesDirectorSell3,336$28.34$94,542.24View SEC Filing  
12/8/2014Evan/ Fa JonesDirectorSell1,000$29.06$29,060.00View SEC Filing  
12/8/2014Vikram JogCFOSell3,950$29.07$114,826.50View SEC Filing  
12/1/2014Gajus Vincent WorthingtonCEOSell6,000$30.03$180,180.00View SEC Filing  
11/17/2014William Maxwell SmithEVPSell3,000$29.52$88,560.00View SEC Filing  
11/12/2014Evan/ Fa JonesDirectorSell5,000$29.55$147,750.00View SEC Filing  
11/7/2014Vikram JogCFOSell3,950$29.45$116,327.50View SEC Filing  
10/24/2014Mai Chan YowInsiderSell10,000$28.00$280,000.00View SEC Filing  
10/7/2014Vikram JogCFOSell3,950$22.65$89,467.50View SEC Filing  
9/15/2014William Maxwell SmithEVPSell3,000$30.83$92,490.00View SEC Filing  
9/8/2014Vikram JogCFOSell3,950$28.57$112,851.50View SEC Filing  
9/2/2014Gajus Vincent WorthingtonCEOSell6,000$28.16$168,960.00View SEC Filing  
8/7/2014Vikram JogCFOSell3,733$26.34$98,327.22View SEC Filing  
8/6/2014Gajus Vincent WorthingtonCEOSell6,000$26.53$159,180.00View SEC Filing  
7/15/2014William Maxwell SmithEVPSell3,000$31.98$95,940.00View SEC Filing  
7/7/2014Vikram JogCFOSell5,427$30.61$166,120.47View SEC Filing  
7/1/2014Gajus Vincent WorthingtonCEOSell6,000$29.72$178,320.00View SEC Filing  
6/16/2014William Maxwell SmithEVPSell3,000$27.64$82,920.00View SEC Filing  
6/2/2014Gajus Vincent WorthingtonCEOSell6,000$26.55$159,300.00View SEC Filing  
5/15/2014William Maxwell SmithEVPSell3,000$28.53$85,590.00View SEC Filing  
5/8/2014Gajus Vincent WorthingtonCEOSell6,000$32.14$192,840.00View SEC Filing  
4/15/2014William Maxwell SmithEVPSell3,000$35.32$105,960.00View SEC Filing  
4/7/2014Vikram JogCFOSell5,091$37.51$190,963.41View SEC Filing  
3/17/2014William Maxwell SmithEVPSell3,000$47.76$143,280.00View SEC Filing  
11/6/2013Gajus Vincent WorthingtonCEOSell11,832$30.03$355,314.96View SEC Filing  
9/3/2013Gajus Vincent WorthingtonCEOSell10,000$20.53$205,300.00View SEC Filing  
9/3/2013William Maxwell SmithEVPSell7,000$20.42$142,940.00View SEC Filing  
8/30/2013Robert JonesEVPSell3,500$20.36$71,260.00View SEC Filing  
8/14/2013Samuel ColellaDirectorSell23,192$19.91$461,752.722,631View SEC Filing  
8/8/2013William Maxwell SmithEVPSell16,000$20.02$320,320.00View SEC Filing  
8/6/2013Gajus Vincent WorthingtonCEOSell10,000$19.49$194,900.00View SEC Filing  
8/6/2013Robert JonesEVPSell3,500$19.16$67,060.00View SEC Filing  
7/8/2013Vikram JogCFOSell5,661$17.05$96,520.05View SEC Filing  
7/1/2013Gajus Vincent WorthingtonCEOSell10,000$17.14$171,400.00View SEC Filing  
7/1/2013William Maxwell SmithEVPSell5,000$17.11$85,550.00View SEC Filing  
6/28/2013Robert C JonesEVPSell3,500$17.11$59,885.00View SEC Filing  
6/7/2013Vikram JogCFOSell5,661$16.00$90,576.00View SEC Filing  
6/3/2013Gajus Vincent WorthingtonCEOSell10,000$17.00$170,000.00View SEC Filing  
6/3/2013William Maxwell SmithInsiderSell5,000$16.96$84,800.00View SEC Filing  
5/31/2013Robert C JonesEVPSell3,500$16.93$59,255.00View SEC Filing  
3/4/2013Mai Chan YowInsiderSell30,000$18.15$544,500.00View SEC Filing  
2/4/2013Robert C JonesEVPSell6,984$16.61$116,004.24View SEC Filing  
2/1/2013Gajus Vincent WorthingtonCEOSell10,000$16.60$166,000.00View SEC Filing  
12/28/2012William Maxwell SmithInsiderSell4,504$14.11$63,551.44View SEC Filing  
12/26/2012William Maxwell SmithInsiderSell6,756$14.36$97,016.16View SEC Filing  
12/14/2012Evan/ Fa JonesDirectorBuy10,000$14.36$143,600.00View SEC Filing  
12/11/2012Evan/ Fa JonesDirectorBuy1,971$14.00$27,594.00View SEC Filing  
12/5/2012William Maxwell SmithEVPSell6,756$14.25$96,273.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Fluidigm (NASDAQ FLDM) News Headlines

Source:
DateHeadline
Fluidigm to Participate in Upcoming Health Care Investor ConferencesFluidigm to Participate in Upcoming Health Care Investor Conferences
finance.yahoo.com - February 14 at 5:00 PM
Free Post Earnings Research Report: Thermo Fisher’s Quarterly Revenue Surged 22%; Adjusted EPS Advanced 16%Free Post Earnings Research Report: Thermo Fisher’s Quarterly Revenue Surged 22%; Adjusted EPS Advanced 16%
finance.yahoo.com - February 14 at 9:24 AM
Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational ProgressFluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress
finance.yahoo.com - February 9 at 9:26 AM
Piper Jaffray Companies Reaffirms "Hold" Rating for Fluidigm (FLDM)Piper Jaffray Companies Reaffirms "Hold" Rating for Fluidigm (FLDM)
www.americanbankingnews.com - February 9 at 12:54 AM
Fluidigm (FLDM) Releases  Earnings Results, Beats Expectations By $0.17 EPSFluidigm (FLDM) Releases Earnings Results, Beats Expectations By $0.17 EPS
www.americanbankingnews.com - February 9 at 12:52 AM
Is Fluidigm Corporation (NASDAQ:FLDM) Undervalued?Is Fluidigm Corporation (NASDAQ:FLDM) Undervalued?
finance.yahoo.com - February 8 at 4:10 PM
Fluidigm Co. (FLDM) Insider Buys $307,185.30 in StockFluidigm Co. (FLDM) Insider Buys $307,185.30 in Stock
www.americanbankingnews.com - February 8 at 3:16 PM
Levin Capital Strategies, L.P. Purchases 50,987 Shares of Fluidigm Co. (FLDM) StockLevin Capital Strategies, L.P. Purchases 50,987 Shares of Fluidigm Co. (FLDM) Stock
www.americanbankingnews.com - February 7 at 12:16 AM
Fluidigm Co. (FLDM) Insider Levin Capital Strategies, L.P. Acquires 152,891 SharesFluidigm Co. (FLDM) Insider Levin Capital Strategies, L.P. Acquires 152,891 Shares
www.americanbankingnews.com - February 2 at 6:16 PM
Fluidigm (FLDM) to Release Earnings on ThursdayFluidigm (FLDM) to Release Earnings on Thursday
www.americanbankingnews.com - February 1 at 1:06 AM
Fluidigm to Report Q4 and Full Year 2017 Financial ResultsFluidigm to Report Q4 and Full Year 2017 Financial Results
finance.yahoo.com - January 25 at 4:12 PM
Levin Capital Strategies, L.P. Acquires 6,871 Shares of Fluidigm Co. (FLDM) StockLevin Capital Strategies, L.P. Acquires 6,871 Shares of Fluidigm Co. (FLDM) Stock
www.americanbankingnews.com - January 24 at 7:04 PM
Daily Insider Ratings Round Up 1/11/18: Altisource, Fluidigm, China ... - Seeking AlphaDaily Insider Ratings Round Up 1/11/18: Altisource, Fluidigm, China ... - Seeking Alpha
seekingalpha.com - January 16 at 10:02 AM
Levin Capital Strategies, L.P. Acquires 100,576 Shares of Fluidigm Co. (FLDM) StockLevin Capital Strategies, L.P. Acquires 100,576 Shares of Fluidigm Co. (FLDM) Stock
www.americanbankingnews.com - January 11 at 9:40 PM
Fluidigm Co. (FLDM) Insider Acquires $66,706.20 in StockFluidigm Co. (FLDM) Insider Acquires $66,706.20 in Stock
www.americanbankingnews.com - January 2 at 7:32 PM
ETFs with exposure to Fluidigm Corp. : January 1, 2018ETFs with exposure to Fluidigm Corp. : January 1, 2018
finance.yahoo.com - January 1 at 4:47 PM
Was Fluidigm Corporation’s (NASDAQ:FLDM) Earnings Growth Better Than Industry?Was Fluidigm Corporation’s (NASDAQ:FLDM) Earnings Growth Better Than Industry?
finance.yahoo.com - December 30 at 9:49 AM
Fluidigm Co. (FLDM) Insider Acquires $159,348.00 in StockFluidigm Co. (FLDM) Insider Acquires $159,348.00 in Stock
www.americanbankingnews.com - December 28 at 6:58 PM
Fluidigm (FLDM) versus Castlight Health (CSLT) Financial SurveyFluidigm (FLDM) versus Castlight Health (CSLT) Financial Survey
www.americanbankingnews.com - December 24 at 5:15 AM
Fluidigm Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Fluidigm Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - December 21 at 4:53 PM
ETFs with exposure to Fluidigm Corp. : December 19, 2017ETFs with exposure to Fluidigm Corp. : December 19, 2017
finance.yahoo.com - December 19 at 4:50 PM
Fluidigm Co. (FLDM) Insider Levin Capital Strategies, L.P. Acquires 24,175 SharesFluidigm Co. (FLDM) Insider Levin Capital Strategies, L.P. Acquires 24,175 Shares
www.americanbankingnews.com - December 18 at 9:26 PM
Fluidigm Co. (FLDM) Insider Buys $108,442.96 in StockFluidigm Co. (FLDM) Insider Buys $108,442.96 in Stock
www.americanbankingnews.com - December 13 at 9:50 PM
ETFs with exposure to Fluidigm Corp. : December 7, 2017ETFs with exposure to Fluidigm Corp. : December 7, 2017
finance.yahoo.com - December 7 at 5:10 PM
Insider Buying: Fluidigm Co. (FLDM) Insider Buys 8,409 Shares of StockInsider Buying: Fluidigm Co. (FLDM) Insider Buys 8,409 Shares of Stock
www.americanbankingnews.com - December 6 at 2:40 PM
Cotiviti (COTV) & Fluidigm (FLDM) Critical ContrastCotiviti (COTV) & Fluidigm (FLDM) Critical Contrast
www.americanbankingnews.com - December 6 at 7:36 AM
Fluidigm (FLDM) versus Castlight Health (CSLT) Head to Head ReviewFluidigm (FLDM) versus Castlight Health (CSLT) Head to Head Review
www.americanbankingnews.com - December 3 at 9:48 PM
Greenway Health (GWAY) and Fluidigm (FLDM) Head-To-Head ReviewGreenway Health (GWAY) and Fluidigm (FLDM) Head-To-Head Review
www.americanbankingnews.com - December 2 at 1:50 AM
Fluidigm Corporation (FLDM) Insider Buys $116,369.80 in StockFluidigm Corporation (FLDM) Insider Buys $116,369.80 in Stock
www.americanbankingnews.com - November 30 at 8:44 PM
ETFs with exposure to Fluidigm Corp. : November 27, 2017ETFs with exposure to Fluidigm Corp. : November 27, 2017
finance.yahoo.com - November 27 at 5:48 PM
Complete Genomics (GNOM) versus Fluidigm Corporation (FLDM) Critical AnalysisComplete Genomics (GNOM) versus Fluidigm Corporation (FLDM) Critical Analysis
www.americanbankingnews.com - November 25 at 11:32 AM
Insider Buying: Fluidigm Corporation (FLDM) Insider Purchases 6,880 Shares of StockInsider Buying: Fluidigm Corporation (FLDM) Insider Purchases 6,880 Shares of Stock
www.americanbankingnews.com - November 21 at 9:34 PM
Fluidigm Corp. :FLDM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017Fluidigm Corp. :FLDM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017
finance.yahoo.com - November 21 at 6:51 PM
Fluidigm to Participate in the 29th Annual Piper Jaffray Healthcare ConferenceFluidigm to Participate in the 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 14 at 7:07 PM
Fluidigm Corporation (FLDM) Lowered to "Strong Sell" at ValuEngineFluidigm Corporation (FLDM) Lowered to "Strong Sell" at ValuEngine
www.americanbankingnews.com - November 10 at 12:58 AM
Fluidigm Corporation (FLDM) Insider Levin Capital Strategies, L.P. Purchases 54,900 SharesFluidigm Corporation (FLDM) Insider Levin Capital Strategies, L.P. Purchases 54,900 Shares
www.americanbankingnews.com - November 9 at 3:28 PM
Edited Transcript of FLDM earnings conference call or presentation 2-Nov-17 9:00pm GMTEdited Transcript of FLDM earnings conference call or presentation 2-Nov-17 9:00pm GMT
finance.yahoo.com - November 3 at 12:17 PM
Fluidigm Corporation to Host Earnings CallFluidigm Corporation to Host Earnings Call
finance.yahoo.com - November 2 at 8:00 PM
Fluidigm Announces Third Quarter Financial Results and Operational ProgressFluidigm Announces Third Quarter Financial Results and Operational Progress
finance.yahoo.com - November 2 at 8:00 PM
Fluidigm reports 3Q lossFluidigm reports 3Q loss
finance.yahoo.com - November 2 at 8:00 PM
Does Fluidigm Corporation’s (FLDM) Debt Level Pose A Serious Problem?Does Fluidigm Corporation’s (FLDM) Debt Level Pose A Serious Problem?
finance.yahoo.com - November 1 at 12:51 AM
Levin Capital Strategies, L.P. Buys 4,227 Shares of Fluidigm Corporation (FLDM) StockLevin Capital Strategies, L.P. Buys 4,227 Shares of Fluidigm Corporation (FLDM) Stock
www.americanbankingnews.com - October 27 at 9:02 PM
Fluidigm Corporation (FLDM) to Release Earnings on ThursdayFluidigm Corporation (FLDM) to Release Earnings on Thursday
www.americanbankingnews.com - October 26 at 6:10 AM
ETFs with exposure to Fluidigm Corp. : October 25, 2017ETFs with exposure to Fluidigm Corp. : October 25, 2017
finance.yahoo.com - October 25 at 10:30 PM
Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in TissuesFluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues
finance.yahoo.com - October 25 at 12:02 AM
Fluidigm Announces Agreement With the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data AnalysisFluidigm Announces Agreement With the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis
finance.yahoo.com - October 25 at 12:02 AM
Levin Capital Strategies, L.P. Purchases 22,363 Shares of Fluidigm Corporation (FLDM) StockLevin Capital Strategies, L.P. Purchases 22,363 Shares of Fluidigm Corporation (FLDM) Stock
www.americanbankingnews.com - October 24 at 4:14 PM
Insider Buying: Fluidigm Corporation (FLDM) Insider Acquires 60,000 Shares of StockInsider Buying: Fluidigm Corporation (FLDM) Insider Acquires 60,000 Shares of Stock
www.americanbankingnews.com - October 23 at 7:28 PM
Levin Capital Strategies, L.P. Buys 144,200 Shares of Fluidigm Corporation (FLDM) StockLevin Capital Strategies, L.P. Buys 144,200 Shares of Fluidigm Corporation (FLDM) Stock
www.americanbankingnews.com - October 23 at 1:32 PM
Fluidigm to Report Q3 2017 Financial Results and Host Conference CallFluidigm to Report Q3 2017 Financial Results and Host Conference Call
finance.yahoo.com - October 19 at 7:25 PM

SEC Filings

Fluidigm (NASDAQ:FLDM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Fluidigm (NASDAQ:FLDM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Fluidigm (NASDAQ FLDM) Stock Chart for Saturday, February, 17, 2018

Loading chart…

This page was last updated on 2/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.